FCM-21524-28545
2 vaccinations
11 coded responses
23 check-ins
11 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
- 2021-01-24
- 2021-01-25
-
2021-01-26
Survey response — days 1–6 daily, dose 1MedDRA: Injection site discharge — Feeling: Good · Joint painsFree text: A juvederm filler injection site began to expell the filler.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Dermal filler reaction — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: cosmetic filler swelled and excreted Juvederm Volbella 1cc (x1) (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
-
2021-02-13
Dose 2 — Pfizer-BioNTech
- 2021-02-13
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Lip swelling — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Extreme swelling of lips and areas where I had cosmetic filler 1.5yrs agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Dizziness, Pre-existing disease, Tinnitus — Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Dermal filler reaction, dizziness & tinitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Mild congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
-
2021-02-20
Survey response — day 7, dose 2MedDRA: Hypersensitivity, Rash — Feeling: Fair · Headache, Rash, not including the immediate area around the injection siteFree text: 2/14 - 2/21 Severe allergic reaction reported to Pfizer. Rash is now appearingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Survey response — day 14, dose 2MedDRA: Rash erythematous — Feeling: GoodFree text: Random red bumpsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-17
Survey response — day 28, dose 2MedDRA: Hypersensitivity — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Clearly noOne reads these reports. I have a severe allergic reaction. No one followed up, which resulted in risk to other!!!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-28
-
2021-05-21
Survey response — 3 months, dose 2MedDRA: Rash erythematous — Feeling: FairFree text: Red rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-05
Call successfulDoes not wish to fill out VAERS report
-
2021-08-15
Survey response — 6 months, dose 2MedDRA: Increased tendency to bruise — Feeling: FairFree text: Bruise more easilyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-13
Survey response — 12 months, dose 2MedDRA: Contusion, Tinnitus — Feeling: FairFree text: Ringing ears & bruisingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): A juvederm filler injection site began to expell the filler.
Systemic reaction (other): cosmetic filler swelled and excreted Juvederm Volbella 1cc (x1) (b)(6)
redacted (b)(6)
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Extreme swelling of lips and areas where I had cosmetic filler 1.5yrs ago
Systemic reaction (other): Dermal filler reaction, dizziness & tinitus
Systemic reaction (other): Mild congestion
Release 4 — day 7, dose 2
Systemic reaction (other): 2/14 - 2/21 Severe allergic reaction reported to Pfizer. Rash is now appearing
Release 4 — day 14, dose 2
Symptoms: Random red bumps
Release 5 — day 28, dose 2
Symptoms: Clearly noOne reads these reports. I have a severe allergic reaction. No one followed up, which resulted in risk to other!!!
Release 8 — 3 months, dose 2
Symptoms: Red rash
Release 9 — 6 months, dose 2
Symptoms: Bruise more easily
Release 11 — 12 months, dose 2
Symptoms: Ringing ears & bruising
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Contusion | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Increased tendency to bruise | ✓ | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Dermal filler reaction | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Injection site discharge | ✓ | ✓ | ✓ |
| SRO | Lip swelling | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Tinnitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release